健帆生物 (300529.SZ)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

财务分析(报告期)(健帆生物)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2024年一季报2023年年报2023年三季报2023年中报2023年一季报2022年年报2022年三季报2022年中报2022年一季报
主要指标:
 营业收入(元) 744,336,658.851,922,348,169.841,485,982,086.001,012,143,747.49572,557,659.762,491,439,432.102,025,701,872.971,554,285,860.96697,355,409.35
 营业利润(元) 348,716,883.42543,819,217.95515,129,256.21339,523,622.35239,179,484.311,029,454,821.021,021,591,465.64880,056,508.49393,768,337.82
 利润总额(元) 339,934,406.15521,020,064.38498,889,014.00329,064,388.32231,678,904.691,016,808,001.511,015,968,520.35877,186,028.49393,157,424.42
 净利润(元) 283,928,180.04425,723,151.05420,436,301.43275,203,101.22195,250,686.39880,918,419.54869,103,293.45746,008,224.71334,390,326.17
 归属于母公司股东的净利润(元) 284,766,143.10436,492,212.29423,655,185.12277,508,333.27196,529,798.71889,537,704.85873,450,879.06748,156,422.55335,207,463.10
盈利能力:
 销售毛利率(%) 78.6880.0380.6680.5580.4282.3483.2883.7984.50
 销售净利率(%) 38.1522.1528.2927.1934.1035.3642.9048.0047.95
 净资产收益率(%) 8.1312.9912.648.375.26----
 总资产报酬率ROA(%) 5.768.898.875.934.03----
 投入资本回报率ROIC(%) 5.758.998.675.603.8219.5119.3917.457.56
营运能力:
 存货周转率(次) 0.461.050.860.670.39----
 应收账款周转率(次) 5.8612.965.663.821.97----
 总资产周转率(次) 0.130.350.280.190.10----
偿债能力:
 资产负债率(%) 44.7643.1243.1842.3136.5333.6729.8029.5527.03
 股东权益比率(%) 55.1656.7856.5857.4463.2266.0369.8069.9872.50
 已获利息倍数(倍) 714.60-14.37-17.58-17.37-25.60-56.06-58.75-63.98411.50
 流动比率 2.993.994.073.724.434.596.407.429.79
 速动比率 2.643.403.453.163.823.885.356.418.65
发展能力:
 营业收入增长率(%) 30.00-22.84-26.64-34.88-17.90-6.8813.6930.8020.46
 营业利润增长率(%) 45.80-47.17-49.58-61.42-39.26-27.400.7520.3317.64
 税后利润增长率(%) 44.90-50.93-51.50-62.91-41.37-25.671.2020.6418.32
 净资产增长率(%) -14.40-11.94-13.41-4.622.136.4113.325.9919.41
 总资产增长率(%) -1.902.346.8316.2017.1212.5415.447.9945.19

前瞻产业研究院